Comment on CMS-2026-1255-0001
HumanaSupportBusiness
Summary: Humana Inc. supports the proposed interoperability standards and transparency measures for prior authorization of drugs, including the use of FHIR and NCPDP standards. However, the company strongly requests that CMS delay the compliance deadline from October 1, 2027, to October 1, 2028, to allow for sufficient resource allocation and implementation planning.
Please find comments from Humana in response to CMS-0062-P.